Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
Depression: Overview01:18

Depression: Overview

254
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
254
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

403
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
403
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

103
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
103
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

516
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
516
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

136
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
136

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessment of validity and comparison of two Spanish versions of the Geriatric Depression Scale.

Frontiers in psychology·2023
Same author

A systematic review evaluating loneliness assessment instruments in older adults.

Frontiers in psychology·2023
Same author

Methods for Gastrointestinal Endoscopy Quantification: A Focus on Hands and Fingers Kinematics.

Sensors (Basel, Switzerland)·2022
Same author

A Systematic Review of Commercial Smart Gloves: Current Status and Applications.

Sensors (Basel, Switzerland)·2021
Same author

Smart conversational agents for the detection of neuropsychiatric disorders: A systematic review.

Journal of biomedical informatics·2020
Same author

Heuristic Evaluation of an IoMT System for Remote Health Monitoring in Senior Care.

International journal of environmental research and public health·2020

相关实验视频

Updated: Jul 10, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.6K

抑郁症查的对话药物:一个系统的审查.

Iván Otero-González1, Moisés R Pacheco-Lorenzo1, Manuel J Fernández-Iglesias1

  • 1atlanTTic, University of Vigo, Vigo, Spain.

International journal of medical informatics
|November 18, 2023
PubMed
概括

这项研究回顾了30种用于抑郁症查的对话药物,发现语音交互提高了它们的有效性. 这些人工智能工具对患者和护理人员的心理健康监测充满希望.

科学领域:

  • * 心理健康技术 心理健康技术
  • * 医疗保健中的人工智能
  • * 人与计算机的交互

背景情况:

  • * 对话代理越来越多地被探索用于心理健康障碍的检测,特别是抑郁症查.
  • *现有的研究重点是基于语音的交互,但也考虑了基于文本和化身的方法.

结论:

  • * 交谈代理提供了一个有价值的工具,用于各种用户群体的心理健康查.
  • *虽然基于文本的交互很常见,但语音集成是一个不断增长的趋势,增强自然性和感知入侵性.
  • * 对话代理的结合方法可以丰富数据采集,以便进行更全面的心理健康评估.
关键词:
人工智能的人工智能是人工智能.交谈代理人 交谈代理人抑郁症 抑郁症 抑郁症机器学习 机器学习自然语言处理自然语言处理.查检查 查检查 查检查

更多相关视频

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.6K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.0K

相关实验视频

Last Updated: Jul 10, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.6K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.6K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.0K